Biologics focus Dahlia Consulting specializes in cell and gene therapy, biologics and biosimilars, indicating a strong cross-selling opportunity for end-to-end regulatory, manufacturing, and quality services for growing biologics programs.

Regulatory capabilities With expertise in CMC and regulatory compliance and submissions, there is potential to upsell end-to-end regulatory strategy, gap assessments, and submission support for clients navigating complex lifecycle regulatory pathways.

Operations uplift Strength in manufacturing, supply chain and quality operations suggests opportunities to assist clients in optimizing operations, accelerating time-to-market, and ensuring compliance in a competitive, startup-like biologics landscape.

Tech and security Proficiency in IT and security, along with cloud and web technologies, opens avenues to offer GMP/CTM IT governance, data integrity, and cybersecurity services tailored to life sciences environments.

Leadership signals Recent executive appointment and mid-sized revenue positioning indicate potential for longer-term engagements with strategic advisory, program/project management support, and scale-up initiatives as clients expand their programs.